Shortly after taking reins at BioMarin, CEO Alexander Hardy laid out three paths the company could take for its struggling ...

Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in | Just as Adverum’s cash reserves ...

Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

But if you want to use CRISPR for gene therapy, you must first get the scissors ... its cells carry relatively few antigens, ...

We unpack the shocking ending of Bugonia, complete with insights from screenwriter Will Tracy about what the characters are up to.

Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...

explained Ivan Morgunov, CEO of Unlimited Bio ... This study is described as the first clinical evaluation of a dual gene-therapy combination in healthy individuals and is aimed to serve as a proof-of ...